Research and Clinical Trials

Children’s Oncology Group Leadership

Seattle Children’s is a founding member of the Children’s Oncology Group (COG), an international organization of childhood cancer specialists. Members work to develop new treatments and reduce long-term effects of cancer and related treatments. Through leadership in the COG, our experts help set the worldwide agenda for pediatric cancer research.

Since March 2020, Seattle Children’s oncologist Dr. Doug Hawkins has led the COG. Hawkins, a national expert on soft tissue cancers, continues to treat children and teens at Seattle Children’s, as he has since 1996.

Thanks to researchers working together through COG, the outlook for children with cancer has improved dramatically. Fifty years ago, children’s cancer was virtually incurable. Today, the combined 5-year survival rate for all cancers is 80%. (See Seattle Children's statistics and outcomes.)

More than 100 COG clinical trials are open at Seattle Children’s at any given time. Seattle Children's has more open COG treatment trials than 98% of pediatric academic medical centers. This means your care team has the widest possible range of trials to consider when recommending options for your child.

“Things like personalized medicine and using the immune system to fight cancer aren’t a futuristic vision anymore. We’re getting closer to the day when some patients may need far less chemotherapy and radiation.”

Dr. Doug Hawkins, Children’s Oncology Group chair. See Rewriting the Rules for Cancer Treatment.

In addition to Dr. Hawkins’s leadership, Seattle Children’s doctors play key roles in COG committees focused on specific conditions.

Ways to Help

Donations from people like you help researchers pursue ideas that could lead to lifesaving treatments for kids with cancer.

Email us to learn more. Or you can donate today and designate the area you’d like to support.